RE: CTEA13 Jan 2021 20:38
I'm arrogant indeed but only most the time.
Yes Afrik-ID is massive if this retail face of CTEA / Synovate strikes game-changing engagements to change the face of infectious disease and vaccine tracking and monitoring. HIV, TB etc dwarfs even COVID.
The company's shareholder engagement is **** poor. Very very **** poor. Buckets of **** more than poor.
My research leads me to believe if these guys pull it off - not just COVID which frankly only presented itself to CTEA in Q2 by luck - the technology can change industries.
I also make a bet that the macro business environment will actively seek CTEAs infrastructure and that of its peers, and as a first mover, CTEA will benefit from that shift.
So I've taken a strategic position. I could've sold in the mid 3s again but I'm not interested in slicing £20k. If my bet is right, then the share price travels and so does the volume.
The misunderstanding, lack of understanding, position of the business adoption curve and lack of communication is why the sp is where it is. When these factors change for the better, people will come.